Skip to content

Research and development of key technology of piezoelectric shock wave and its clinical application-application in patients with nonunion

Research and development of key technology of piezoelectric shock wave and its clinical application-application in patients with nonunion

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092913
Enrollment
Unknown
Registered
2024-11-26
Start date
2024-11-30
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone nonunion

Interventions

Test group 1:Ultrasonic treatment group+routine exercise rehabilitation training
Test group 2:Shock wave therapy group+routine exercise rehabilitation training
Test group 3:Shock wave+ultrasonic therapy group+routine exercise rehabilitation training

Sponsors

The Second Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: ? It conforms to the diagnosis points of nonunion, and the fracture site has no signs of callus formation and fracture healing after CT or X-ray imaging examination for 6-12 months. ? Age 18-70 years; ? No obvious cognitive impairment, mental illness, etc., and can cooperate to complete the treatment; ? All patients were informed and agreed to the treatment.

Exclusion criteria

Exclusion criteria: ? Patients with serious heart, liver, lung, kidney and other important organ diseases; ? Patients with coagulation dysfunction or symptoms who take anticoagulant drugs and thrombosis; ? Taking antispasmodic drugs, local injection of botulinum toxin, phenol or alcohol, etc. ? Patients with local tumor and immature bone tissue; (5) local infection and skin ulceration; ? Patients with severe atrophic nonunion whose bone defect is more than 2cm and who can't cooperate with the investigator.

Design outcomes

Primary

MeasureTime frame
Pain visual analogue scale;

Secondary

MeasureTime frame
AQoL-4D scale score;

Countries

China

Contacts

Public ContactSong Yufeng

The Second Hospital of Shanxi Medical University

songyufeng@sxmu.edu.cn+86 136 3347 5405

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026